ArticleGastroenterology & hepatology2024
Results From the 52-Week Phase 2b VOYAGE Trial of VK2809 in Patients With Biopsy-Confirmed Non-Alcoholic Steatohepatitis and Fibrosis: A Randomized, Placebo-Controlled Trial.
No numbers read from the abstract.
8 papers cite it
this papercites it